GSE217552 fisetin 3 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE217552_fisetin_3_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE217552_fisetin_3_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE217552_fisetin_3_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE217552_fisetin_3_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

TCF21 antisense RNA inducing promoter demethylation

Gene

ELOVL2 antisense RNA 1

Gene

long intergenic non-protein coding RNA 2101

Gene

ribosomal protein L4 pseudogene 5

Gene

small proline rich protein 2D

Gene

small proline rich protein 2A

Gene

S100 calcium binding protein A7A

Gene

Rho guanine nucleotide exchange factor 37

Gene

TSC complex subunit 1

Gene

TLR4 interactor with leucine rich repeats

  • Gene

    TCF21 antisense RNA inducing promoter demethylation


  • Gene

    ELOVL2 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 2101


  • Gene

    ribosomal protein L4 pseudogene 5


  • Gene

    small proline rich protein 2D


  • Gene

    small proline rich protein 2A


  • Gene

    S100 calcium binding protein A7A


  • Gene

    Rho guanine nucleotide exchange factor 37


  • Gene

    TSC complex subunit 1


  • Gene

    TLR4 interactor with leucine rich repeats

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.